SCHEMBL7721313

SCHEMBL7721313

OCCOc1ccc(C(/C(=C/CCl)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
ALDH1A1 P00352 3/20 0.46
RECQL P46063 1/20 0.46
CYP19A1 P11511 5/20 0.40
NPSR1 Q6W5P4 1/20 0.37
NR1I2 O75469 1/20 0.37
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
LTA4H P09960 1/20 0.36
KMT2A Q03164 1/20 0.36
PKM P14618 1/20 0.35
CYP3A4 P08684 1/20 0.34
GPR88 Q9GZN0 2/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
LMNA P02545 1/20 0.33
HTR6 P50406 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13506110 1.00 GAA (0.48) GAAALDH1A1RECQLCYP19A1NPSR1
SCHEMBL7561836 1.00 GAA (0.48) GAAALDH1A1RECQLCYP19A1NPSR1
SCHEMBL7948711 0.85 HTR1B (0.49) ALDH1A1CYP19A1NPSR1ESR1KMT2A
SCHEMBL4620169 0.85 GAA (0.51) GAAALDH1A1RECQLCYP19A1NPSR1
SCHEMBL11209066 0.83 ESR1 (0.54) ALDH1A1NPSR1ESR1ESR2LTA4H
SCHEMBL19639015 0.79 CNR1 (0.40) ALDH1A1CYP19A1ESR1ESR2KMT2A
SCHEMBL10893461 0.78 ALDH1A1 (0.41) GAAALDH1A1CYP19A1NPSR1ESR1
SCHEMBL9859772 0.76 CYP2D6 (0.52) ALDH1A1NPSR1NR1I2ESR1ESR2
SCHEMBL11212723 0.75 LMNA (0.47) GAALTA4HLMNA
SCHEMBL8611247 0.74 CYP19A1 (0.51) ALDH1A1CYP19A1NPSR1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104788300-B Ospemifene polymorphic substance 南京华威医药科技开发有限公司 2017-01-11 CN disclosed
CN-104788300-A Ospemifene polymorphic substance NANJING HUAWE MEDICAL TECHNOLOGY DEV CO LTD 2015-07-22 CN disclosed
US-6395785-B1 ANTICHOLESTEROL AGENTS; HORMONE REPLACEMENT THERAPY ORION CORPORATION (FI) 2002-05-28 US disclosed